[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$cybn

$CYBN sees positive trial results and FDA breakthrough designation, driving sector optimism. Trading volume is up, with institutional interest growing, according to recent social posts and engagements.

About $cybn

Cybin ($CYBN) is a biotechnology company focused on the research and development of psychedelic-based therapeutics.

Insights #

$cybn sentiment is up XXX% from the previous week.

Engagements: XXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXXX +8.80%
1 Month: XXXXXX -XX%
1-Year High: XXXXXX on 2025-05-27
1-Year Low: X on 2025-09-17

Social Network	X	TikTok	YouTube
Engagements	XXX	X	X

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-17

Social Network	X	TikTok	YouTube
Mentions	XX	X	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $cybn in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-17

The most influential creators that mention $cybn in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@jrouldz	X	XXXXXX	X	XXX
@PsychedStocks	X	XXX	X	XX
@Matt_vlietstra	X	XXXXX	X	XX
@c2412345	X	XXX	X	XX
@PsychedVantage	X	XXXXX	X	XX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XX% -XX%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-10-09

Most Supportive Themes

Positive Clinical Trial Results: (45%) Posts highlight positive outcomes from CYB003 and CYB004 trials, fueling optimism about the company's progress in psychedelic treatments.
Sector Momentum and Institutional Interest: (30%) Mentions of increased trading volume and institutional interest in psychedelic stocks, including $CYBN, suggest growing confidence in the sector.
Regulatory Advancements: (15%) News of FDA breakthrough therapy designation and supportive guidance for psychedelic development boosts investor sentiment.

Most Critical Themes

Market Volatility: (10%) Concerns about overall market conditions and their potential impact on the stock's performance are present.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXX	XX%	XX	X%
TikTok	X	X%	X	X%	X	X%
YouTube	X	X%	X	X%	X	X%

Total	XXX	XX%	XXX	XX%	XX	X%

Top assets mentioned In the posts about $cybn in the last XX hours

ATAI Life Sciences (ATAI) ATAI Life Sciences (ATAI) McKesson Corporation (MCK) McKesson Corporation (MCK) AAR Corp. (AIR) Archer Aviation Inc. (ACHR) AST SpaceMobile, Inc. Class A Common Stock (ASTS) Intuitive Machines, Inc. (LUNR) GitLab Inc. Class A Common Stock (GTLB) Intuitive Machines, Inc. (LUNR)

Top topics mentioned In the posts about $cybn in the last XX hours

atai life, stocks bitcoin treasuries, $atai, $mnmd, $cmps, investment, mental health, mckesson, stocks healthcare, $mck, $air, $gtn, stocks, $ghrs, $aeva, $achr, $asts, $bksy, $clpt, $reymi, wellness, $lunr, $gtlb, intuitive machines, stocks industrials, money, acquisition